^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

VT02956

i
Other names: VT02956
News
Trials
Company:
Vivace Therap
Drug class:
LATS kinase inhibitor
News
Trials